Solas Capital Management LLC Takes Position in Vertex Pharmaceuticals Incorporated $VRTX
Solas Capital Management LLC acquired a new position in shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 1,889,366 shares of the pharmaceutical company’s stock, valued at approximately $20,311,000. Vertex Pharmaceuticals comprises about 10.9% of Solas Capital […]
25 Aug 13:14 · The Markets Daily